Saudi SFDA Regulatory News
Latest regulatory updates, standard revisions, and guidance publications in the medical device compliance space.
Regulatory Framework
Regulatory Authority: Saudi Food and Drug Authority (SFDA) -- Medical Devices Sector
Key Legislation:
- Medical Devices Law (Royal Decree M/54)
- Medical Devices Executive Regulations
- MDS-REQ1: Requirements for Medical Device Marketing Authorization (MDMA)
Classification: Risk-based, 4 classes:
- Class A (low risk) | Class B (low-medium risk) | Class C (medium-high risk) | Class D (high risk)
- Classification determined by manufacturer based on intended use, risk level, invasiveness, and duration of use
Registration Pathway:
- Appoint a local Authorized Representative (AR) licensed by SFDA
- Classify the device using MDS-G008 guidance
- Prepare technical dossier per class requirements (ISO 13485 required for Class B+)
- Submit MDMA application via GHAD electronic system
- SFDA review and issuance of MDMA certificate (Arabic & English)
Key Requirements:
- Local AR mandatory for foreign manufacturers
- Arabic labeling and IFU required
- ISO 13485 certificate required for Class B and above
- Post-Market Surveillance Plan required
- UDI implementation in progress
Current Key Guidance:
Latest Updates
SFDA Intercepts Over 301 Tons of Non-Compliant Food Products in Q2 2026
2026-07-31 | Saudi SFDA | Regulation Update | !! MEDIUM
The Saudi Food and Drug Authority (SFDA) intercepted over 301 tons of non-compliant food products in Q2 2026, highlighting its robust enforcement and digital monitoring capabilities. While the action directly impacts food importers and distributors, medical device manufacturers and regulatory professionals should note SFDA's growing use of digital tools for market surveillance, signaling a broader compliance expectation across all regulated sectors.
Tags: sfda_enforcement, food_safety_interception, digital_transformation, saudi_market_surveillance
SFDA CEO Conducts Field Inspections of Hajj Preparations in Makkah and Eastern Region
2026-07-31 | Saudi SFDA | Regulation Update | ! LOW
The CEO of the Saudi Food and Drug Authority (SFDA) conducted on-site inspections at several facilities in Makkah Al-Mukarramah and the Eastern Region to verify the Authority's readiness for the upcoming Hajj season. The visits focused on ensuring that regulatory and technical services for food, drugs, and medical devices are fully prepared to safeguard pilgrims. While no immediate industry action is required, suppliers of products used during Hajj should expect intensified oversight and compliance checks.
Tags: hajj, sfda_inspection, regulatory_readiness
SFDA Reports 18% Increase in Licensed Drug and Cosmetic Factories and Warehouses in 2025
2026-07-31 | Saudi SFDA | Regulation Update | !! MEDIUM
The Saudi Food and Drug Authority (SFDA) announced an 18% growth in the number of licensed pharmaceutical and cosmetic factories and warehouses during 2025, crediting its digital transformation and the 'Saudi Green Card' licensing platform. This increase reflects broader regulatory modernization efforts, and manufacturers and warehouse operators in these sectors should continue ensuring their facilities are properly licensed through the online system to maintain compliance.
Tags: sfda, digital_transformation, licensing
SFDA Grants Marketing Authorization for Advanced Biotech Medical Device for Early Alzheimer's Detection
2026-07-31 | Saudi SFDA | Regulation Update | !! MEDIUM
The Saudi Food and Drug Authority (SFDA) has granted marketing authorization for a medical device that uses advanced biotechnology to enable early detection of Alzheimer's disease. This approval permits the device to be marketed and used in Saudi Arabia, affecting diagnostic device manufacturers and healthcare providers in the region. Regulatory professionals should note this as a significant development in the approval pathway for innovative diagnostic technologies.
Tags: medical_device_approval, alzheimers_disease, biotechnology
SFDA Advances Health Innovation via Clinical Trials, Gene Therapies, and Digital Transformation of Drug Safety
2026-07-31 | Saudi SFDA | Regulation Update | !!! HIGH
The Saudi Food and Drug Authority (SFDA) announced new initiatives to support clinical trials and gene therapies, while also leading a digital transformation in drug and cosmetic safety regulation. The move aims to accelerate innovative treatment development and enhance regulatory oversight. Regulatory professionals should anticipate updated guidelines and new digital platform requirements.
Tags: clinical_trials, gene_therapy, digital_transformation
SFDA Rejects Marketing Authorization for Software Predicting Diabetes 4 Years Before Onset Despite European Marketing
2026-07-31 | Saudi SFDA | Regulation Update | !! MEDIUM
The Saudi Food and Drug Authority (SFDA) has denied marketing authorization for a software medical device designed to predict diabetes four years before it occurs, citing failure to meet required regulatory standards. The device is already marketed in some European countries, highlighting differing evidence and compliance expectations. This decision affects manufacturers targeting the Saudi market with AI-based diagnostic tools, emphasizing the need for robust clinical validation and full adherence to SFDA’s technical requirements for software as a medical device.
Tags: software_as_medical_device, ai_diagnostics, marketing_rejection, diabetes_prediction, sfda
SFDA Approves Marketing of Novel Brain Stimulation Device for Parkinson's Disease Treatment
2026-07-31 | Saudi SFDA | Regulation Update | !! MEDIUM
The Saudi Food and Drug Authority (SFDA) has granted marketing authorization for a medical device that uses modern brain stimulation technology to treat Parkinson's disease. This approval allows the device to be placed on the Saudi market, offering patients a new non-pharmacological option. Manufacturers and distributors should note the regulatory pathway for innovative neurostimulation devices in Saudi Arabia and ensure ongoing compliance with SFDA post-market requirements. The device likely falls under a high-risk classification, requiring vigilance and reporting.
Tags: sfda, medical_device_approval, brain_stimulation, parkinsons_disease
SFDA NCMDR Weekly Update WU2631 (26 July 2026): Medical Device Safety Alerts
2026-07-26 | Saudi SFDA | Safety Communication | !! MEDIUM
The Saudi FDA National Center for Medical Devices Reporting (NCMDR) issued Weekly Update WU2631 on 26 July 2026, compiling recent medical device safety alerts, field safety notices, and recall actions. The report identifies affected devices and manufacturers, and outlines required corrective measures for healthcare providers and suppliers in Saudi Arabia. Stakeholders should review the full report promptly and implement the specified actions to mitigate risks to patient safety.
Tags: safety_alert, weekly_update, saudi_sfda, ncmdr, field_safety_notice
SFDA NCMDR Weekly Safety Update WU2630 (19 July 2026) Released
2026-07-19 | Saudi SFDA | Safety Communication | !! MEDIUM
The Saudi Food and Drug Authority's National Center for Medical Devices Reporting (NCMDR) has published Weekly Update report WU2630. This report compiles recent medical device safety alerts, field safety notices, and adverse event reports for healthcare providers and manufacturers. Stakeholders are advised to review the document, identify affected devices listed within, and implement any recommended corrective actions to ensure continued compliance and patient safety.
Tags: sfda, ncmdr, weekly_safety_update, medical_device_reporting, field_safety_notice
SFDA NCMDR Weekly Update WU2629 (12 July 2026) – Medical Device Safety Report
2026-07-12 | Saudi SFDA | Safety Communication | !! MEDIUM
The Saudi Food and Drug Authority's National Center for Medical Devices Reporting (NCMDR) released Weekly Update WU2629 on 12 July 2026, summarizing recent medical device field safety notices, recalls, and safety alerts from the week. Affected devices and manufacturers are detailed in the report, and all stakeholders—including importers, distributors, and healthcare providers—should immediately review the notices and implement necessary corrective actions to maintain compliance and safeguard patients.
Tags: saudi_sfda, ncmdr, weekly_update, medical_device_safety, field_safety_notice
SFDA NCMDR Weekly Safety Update WU2628 Released for 5 July 2026
2026-07-05 | Saudi SFDA | Safety Communication | !! MEDIUM
The Saudi Food and Drug Authority's National Center for Medical Devices Reporting (NCMDR) has published Weekly Update WU2628, dated 5 July 2026. This report compiles recent medical device safety alerts and field safety corrective actions from manufacturers. Affected stakeholders include healthcare providers, distributors, and patients using the listed devices. All relevant parties should review the full report and implement any recommended actions promptly to ensure patient safety.
Tags: saudi_sfda, ncmdr_weekly, safety_alert, medical_devices
SFDA Hosts Workshops on Medical Device Clinical Trials and Health Tech at GHE
2026-07-03 | Saudi SFDA | Regulation Update | !! MEDIUM
The Saudi Food and Drug Authority (SFDA) organized two specialized workshops at the Global Health Exhibition (GHE) covering clinical trial requirements for medical devices and emerging healthcare technologies. The sessions targeted manufacturers, researchers, and healthcare professionals to enhance understanding of regulatory frameworks and encourage compliant innovation. Key discussions included trial design, ethical standards, and technology integration in the medical device sector.
Tags: clinical_trials, healthcare_technologies, sfda_workshop, medical_devices, regulatory_education
SFDA Signs MoU with AAMI to Enhance Medical Device Standards
2026-07-03 | Saudi SFDA | Regulation Update | !! MEDIUM
On July 18, 2023, the Saudi Food and Drug Authority (SFDA) signed a Memorandum of Understanding with the Association for the Advancement of Medical Instrumentation (AAMI) to collaborate on medical device standards. The partnership aims to align Saudi requirements with international best practices, affecting manufacturers seeking market access. Companies should monitor for forthcoming standards updates and guidance from this cooperation to ensure ongoing compliance.
Tags: medical_device_standards, SFDA, AAMI, regulatory_cooperation
SFDA Strengthens Global Standing by Regulating Clinical Studies for Innovative Medical Devices and Supplies
2026-07-03 | Saudi SFDA | Regulation Update | !! MEDIUM
The Saudi Food and Drug Authority (SFDA) is advancing its global regulatory position by organizing and overseeing clinical studies for innovative medical devices and supplies. This initiative aims to foster local clinical research, align with international best practices, and encourage medical device innovation within the Kingdom. Medical device manufacturers, clinical research organizations, and healthcare professionals involved in device trials will be directly affected as the authority reinforces its oversight framework.
Tags: clinical_studies, innovative_medical_devices, sfda, regulatory_oversight
SFDA NCMDR Weekly Safety Update WU2627 – Medical Device Field Safety Notices and Recalls
2026-06-28 | Saudi SFDA | Safety Communication | !! MEDIUM
The Saudi Food and Drug Authority (SFDA) National Center for Medical Devices Reporting (NCMDR) published Weekly Update WU2627 on 28 June 2026, compiling new field safety corrective actions and recalls for medical devices. Healthcare facilities and distributors should review the listed devices and affected manufacturers to identify products requiring action and implement the recommended safety measures. The update covers multiple device categories and includes details on risk mitigation steps.
Tags: saudi_sfda, ncmdr, weekly_update, safety_notice, recall
SFDA NCMDR Weekly Update (WU2626) – Medical Device Safety Alerts and Adverse Event Reports
2026-06-21 | Saudi SFDA | Safety Communication | !! MEDIUM
The Saudi Food and Drug Authority (SFDA) released Weekly Update WU2626 through the National Center for Medical Devices Reporting (NCMDR), detailing recent safety alerts, adverse event reports, and field safety corrective actions concerning medical devices in the Saudi market. Healthcare providers, importers, and manufacturers should review the listed devices and implement any recommended actions to ensure patient safety and regulatory compliance.
Tags: medical_devices, safety_alert, sfda, ncmdr, weekly_update, saudi_arabia
SFDA NCMDR Weekly Safety Update WU2625 – 14 June 2026
2026-06-14 | Saudi SFDA | Safety Communication | !! MEDIUM
The Saudi Food and Drug Authority (SFDA) National Center for Medical Devices Reporting (NCMDR) has released Weekly Update WU2625 on 14 June 2026. This report contains recent adverse event notifications, field safety corrective actions, and recall notices for medical devices marketed in Saudi Arabia. Healthcare providers and device manufacturers should review the listed affected products and implement any required risk mitigation measures as specified in the update.
Tags: saudi_fda, ncmdr, medical_device_safety, weekly_report, recall_alert
SFDA NCMDR Weekly Update WU2624 (07 June 2026) Issued
2026-06-07 | Saudi SFDA | Safety Communication | !! MEDIUM
The Saudi Food and Drug Authority's National Center for Medical Devices Reporting (NCMDR) has published Weekly Update WU2624 on 07 June 2026. This report summarizes recent medical device safety alerts, listing affected products and manufacturers. Healthcare providers and stakeholders should review the update to identify any necessary corrective actions or field safety notices relevant to their facilities.
Tags: saudi_fda, ncmdr, weekly_update, safety_alert
SFDA NCMDR Weekly Safety Update WU2622 (24 May 2026) Released
2026-05-24 | Saudi SFDA | Safety Communication | !! MEDIUM
The Saudi Food and Drug Authority's National Center for Medical Devices Reporting (NCMDR) has published Weekly Update WU2622, dated 24 May 2026. This report compiles recent field safety notices, recalls, and adverse event reports affecting medical devices registered in the Kingdom. Manufacturers, authorized representatives, and healthcare providers should review the listed alerts to identify any devices within their inventory and implement required corrective actions promptly.
Tags: sfda, ncmdr, weekly_safety_update, field_safety_notice, medical_device_recall